• 出版社/出版日：Mordor Intelligence / 2020年4月20日
|Single User||￥442,000 (USD4,250)||▷ お問い合わせ|
|Team User||￥494,000 (USD4,750)||▷ お問い合わせ|
|Corporate License||￥780,000 (USD7,500)||▷ お問い合わせ|
The Vascular Screening Devices Market is expected to register a CAGR of 5.9% during the forecast period. The growing burden of vascular diseases and the rising geriatric population might be the key factors in the vascular screening devices market. Peripheral artery disease is a condition wherein the peripheral vessels are built up with fat and cholesterol deposits. According to the Current Atherosclerosis Reports, in 2018, peripheral artery disease affected almost 200 million people globally. Moreover, peripheral artery disease is more prevalent in the older population. According to a similar source, the incidence of peripheral artery disease is observed to increase by approximately 20% in the population aged 70 and over. Moreover, rising awareness of non-invasive techniques for diagnostic purposes is expected to drive the market. Ankle, Branchial Index (ABI), toe-branchial index, and photoplethysmogram are some of the non-invasive techniques used for the diagnosis of vascular diseases. According to the study of 2018 published in Annals of Vascular Surgery, these tests were observed to be less painful for patients and consumed less time. Hence, such factors are expected to propel the vascular screening devices market growth.
Key Market Trends
Portable Segment is Expected to Hold a Major Market Share in the Vascular Screening Devices Market
Portable vascular screening test are hand-held devices which are in screening test. The rising burden of cardiovascular disease and other vascular conditions. According to the World Health Organization, in 2017, approximately 17.9 million people died due to cardiovascular diseases and it’s the leading cause of death globally. For several of cardiovascular diseases, the vascular screening tests becomes very important for further analysis and treatment.
Furthermore, according to the assessment study of the International Journal of Cardiology, 2019, it was observed that the handheld device accurately measured the maximum plaque height and total plaque area in the carotid artery. Hence, early diagnosis and treatment are of utmost importance which is expected to impact positively on the vascular screening test market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America expected to hold a major market share in the global vascular screening devices market due to increasing vascular diseases such as coronary artery disease, renal artery diseases, carotid artery aneurysm, etc. Coronary artery disease is the most affected heart disease. According to the Centre for Disease Control and Prevention, in 2017, around 365,914 people died due to coronary artery disease in the United States. Furthermore, in 2019, around 18.2 million population aged 20 and above had coronary artery disease. Hence, the aforementioned factors are expected to boost up the demand for vascular screening devices in North America.
In the current scenario, few of the companies that are dominating the Vascular Screening Devices Market are Fukuda, Unetixs Vascular Inc., Collaborative Care Diagnostics, LLC (Biomedix), CorVascular Diagnostics, LLC, Koven Technology, Inc., D.E. Hokanson, Inc., enverdis GmbH, OMRON HEALTHCARE Co., Ltd., Viasonix and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Vascular Diseases
4.2.2 Increasing Aging Population
4.3 Market Restraints
4.3.1 Reimbursement Issues
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.2 By End User
5.2.2 Diagnostic Centres/Clinics
5.3.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.3.4 Rest of the World
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Collaborative Care Diagnostics, LLC (Biomedix)
6.1.2 CorVascular Diagnostics, LLC
6.1.3 D.E. Hokanson, Inc.
6.1.4 enverdis GmbH
6.1.6 Koven Technology, Inc.
6.1.7 OMRON HEALTHCARE Co., Ltd.
6.1.8 Shenzhen Mindray Bio-Medical Electronics Co., Ltd
6.1.9 Unetixs Vascular Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS